Filing Details

Accession Number:
0001179110-15-005718
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-02 10:09:21
Reporting Period:
2015-04-02
Filing Date:
2015-04-02
Accepted Time:
2015-04-02 10:09:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1544227 Ovascience Inc. OVAS Pharmaceutical Preparations (2834) 451472564
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551614 Michelle Dipp C/O Ovascience, Inc.
215 First Street, Suite 240
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-02 1,000 $32.49 850,608 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 684,027 Indirect By Longwood Fund GP, LLC
Footnotes
  1. The Reporting Person, Richard Aldrich and Christoph Westphal, M.D., Ph.D. (the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund GP, LLC. Each of the Managers disclaims beneficial ownership of the shares held by Longwood Fund GP, LLC, except o the extent of their respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or any other purpose.